Patents by Inventor Diva Chan
Diva Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240099950Abstract: The disclosure provides cosmetic compositions including cannabigerol (CBG), as well as methods of using the same for reducing skin redness, improving skin barrier functionality, brightening the skin of a subject, and enhancing the outward appearance of the skin of a subject (e.g., a male or female human subject).Type: ApplicationFiled: January 11, 2022Publication date: March 28, 2024Applicant: Amyris, Inc.Inventors: Diva CHAN, Ro OTERI, Ashlee NUNES
-
Publication number: 20230060807Abstract: Provided herein antiperspirant composition formulations that contain hemisqualane and lack organosilicon compounds. The hemisqualane provides the carrier and emollient activities that are typically supplied by an organosilicon compound. The antiperspirant formulations provided herein have a benefit of not releasing organosilicon compounds into the environment during and after their use.Type: ApplicationFiled: November 6, 2020Publication date: March 2, 2023Inventors: Diva CHAN, RO OTERI, Ashlee NUNES
-
Publication number: 20220362170Abstract: Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.Type: ApplicationFiled: November 6, 2020Publication date: November 17, 2022Inventors: Diva CHAN, Ro OTERI, Ashlee NUNES
-
Patent number: 11219586Abstract: Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.Type: GrantFiled: July 14, 2021Date of Patent: January 11, 2022Assignee: Amyris, Inc.Inventors: Diva Chan, Ro Oteri, Ashlee Nunes
-
Patent number: 11213467Abstract: Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.Type: GrantFiled: March 19, 2021Date of Patent: January 4, 2022Assignee: Amyris, Inc.Inventors: Diva Chan, Ro Oteri, Ashlee Nunes
-
Publication number: 20210338549Abstract: Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.Type: ApplicationFiled: July 14, 2021Publication date: November 4, 2021Inventors: Diva CHAN, Ro OTERI, Ashlee NUNES
-
Publication number: 20210205191Abstract: Provided herein are compositions for delivering one or more cannabinoids to the skin of a subject and methods of using the compositions to deliver the one or more cannabinoids to the skin of a subject. The compositions contain a carrier that facilitates the delivery and permeation of cannabinoids to and through the skin. The carriers of the compositions contain squalane or mixtures of squalane and hemisqualane. The compositions described herein may serve as the base for the preparation of various cosmetics or various pharmaceuticals. The cosmetics or pharmaceuticals may be used to reduce inflammation, control pain, or prevent aging of the skin of a subject.Type: ApplicationFiled: March 19, 2021Publication date: July 8, 2021Inventors: Diva CHAN, Ro OTERI, Ashlee NUNES
-
Publication number: 20200390669Abstract: The present invention provides compositions and methods of using the compositions as personal care products and other consumer and industrial products, wherein the compositions comprise bio-based farnesene and/or compounds derived from the bio-based farnesene.Type: ApplicationFiled: June 26, 2020Publication date: December 17, 2020Inventors: Ross Eppler, Diva CHAN
-
Patent number: 10695273Abstract: The present invention provides compositions and methods of using the compositions as personal care products and other consumer and industrial products, wherein the compositions comprise bio-based farnesene and/or compounds derived from the bio-based farnesene.Type: GrantFiled: September 29, 2016Date of Patent: June 30, 2020Assignee: AMYRIS, INC.Inventors: Ross Eppler, Diva Chan
-
Publication number: 20190054008Abstract: The present invention provides methods, compositions and kits for extracting botanical compounds from plant parts using a carrier medium comprising a bio-based farnesene, a hydrocarbon composition derived from the bio-based farnesene or a combination thereof. In certain embodiments, rose petals are used as a plant material, and a squalane composition derived from bio-based farnesene is used as a carrier medium.Type: ApplicationFiled: September 22, 2016Publication date: February 21, 2019Applicant: AMYRIS, INC.Inventor: Diva CHAN
-
Publication number: 20180289601Abstract: The present invention provides compositions and methods of using the compositions as personal care products and other consumer and industrial products, wherein the compositions comprise bio-based farnesene and/or compounds derived from the bio-based farnesene.Type: ApplicationFiled: September 29, 2016Publication date: October 11, 2018Inventors: Ross Eppler, Diva CHAN
-
Publication number: 20120071513Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.Type: ApplicationFiled: November 28, 2011Publication date: March 22, 2012Applicant: COMPASS PHARMACEUTICALS LLCInventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
-
Publication number: 20110178087Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.Type: ApplicationFiled: March 30, 2011Publication date: July 21, 2011Applicant: Compass Pharmaceuticals LLC.Inventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
-
Publication number: 20090018145Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreating carcinomas) and mesotheliomas.Type: ApplicationFiled: October 18, 2005Publication date: January 15, 2009Applicant: Compass Pharmaceuticals LLCInventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
-
Publication number: 20070244116Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate, and/or modulate kinase receptor, particularly c-Met, KDF, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.Type: ApplicationFiled: May 24, 2007Publication date: October 18, 2007Applicant: EXELIXIS, INC.Inventors: LYNNE BANNEN, Diva Chan, Jeff Chen, Lisa Dalrymple, Timothy Forsyth, Tai Huynh, Vasu Jammalamadaka, Richard Khoury, James Leahy, Morrison Mac, Grace Mann, Larry Mann, John Nuss, Jason Parks, Craig Takeuchi, Yong Wang, Wei Xu
-
Publication number: 20070225307Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate, and/or modulate kinase receptor, particularly c-Met, KDF, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.Type: ApplicationFiled: May 24, 2007Publication date: September 27, 2007Applicant: EXELIXIS, INC.Inventors: Lynne Bannen, Diva Chan, Jeff Chen, Lisa Dalrymple, Timothy Forsyth, Tai Huynh, Vasu Jammalamadaka, Richard Khoury, James Leahy, Morrison Mac, Grace Mann, Larry Mann, John Nuss, Jason Parks, Craig Takeuchi, Yong Wang, Wie Xu
-
Publication number: 20070054928Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides quinazolines and quinolines which inhibit, regulate and/or modulate kinase receptor, particularly c-Met, KDR, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, and compositions which contain these compounds.Type: ApplicationFiled: October 26, 2006Publication date: March 8, 2007Applicant: EXELIXIS, INC.Inventors: Lynne Bannen, Diva Chan, Jeff Chen, Lisa Dalrymple, Timothy Forsyth, Tai Huynh, Vasu Jammalamadaka, Richard Khoury, James Leahy, Morrison Mac, Grace Mann, Larry Mann, John Nuss, Jason Parks, Craig Takeuchi, Yong Wang, Wei Xu